Lunsumio Velo 50242-0177
Generic: Mosunetuzumab
Product NDC
50242-0177- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 19, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761263
Need to source Lunsumio Velo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mosunetuzumab | 5 mg/.5mL |
Packaging Options(1)
1 VIAL, GLASS in 1 CARTON (50242-177-01) / .5 mL in 1 VIAL, GLASS